Australia markets close in 5 hours 2 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1700-0.0300 (-0.94%)
At close: 04:00PM EDT
3.1600 -0.01 (-0.32%)
After hours: 07:30PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 482.09M
Enterprise value 589.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.54
Price/book (mrq)12.60
Enterprise value/revenue 4.46
Enterprise value/EBITDA -1.55

Trading information

Stock price history

Beta (5Y monthly) 1.81
52-week change 3111.92%
S&P500 52-week change 321.83%
52-week high 33.9300
52-week low 30.5000
50-day moving average 33.3160
200-day moving average 32.3095

Share statistics

Avg vol (3-month) 32.39M
Avg vol (10-day) 32.19M
Shares outstanding 5150.65M
Implied shares outstanding 6152.08M
Float 8112.23M
% held by insiders 10.70%
% held by institutions 180.72%
Shares short (28 June 2024) 432.82M
Short ratio (28 June 2024) 414.92
Short % of float (28 June 2024) 428.23%
Short % of shares outstanding (28 June 2024) 421.79%
Shares short (prior month 31 May 2024) 430.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 313 Jan 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -61.28%
Operating margin (ttm)-13.84%

Management effectiveness

Return on assets (ttm)-18.45%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)132.1M
Revenue per share (ttm)0.90
Quarterly revenue growth (yoy)17.10%
Gross profit (ttm)N/A
EBITDA -61.88M
Net income avi to common (ttm)-80.95M
Diluted EPS (ttm)-0.5400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)71.52M
Total cash per share (mrq)0.47
Total debt (mrq)179.17M
Total debt/equity (mrq)N/A
Current ratio (mrq)2.47
Book value per share (mrq)-0.22

Cash flow statement

Operating cash flow (ttm)-43.41M
Levered free cash flow (ttm)-11.77M